BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7408402)

  • 21. Effect of nifedipine on digoxin kinetics in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Kjaer K; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1982 Nov; 32(5):562-5. PubMed ID: 7127997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quinidine-digoxin interaction in patients with impaired renal function.
    Fichtl B; Doering W; Seidel H
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):229-33. PubMed ID: 6862727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of probenecid on the renal and biliary clearances of digoxin in man.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin disposition kinetics in dogs before and during azotemia.
    Gierke KD; Perrier D; Mayersohn M; Marcus FI
    J Pharmacol Exp Ther; 1978 May; 205(2):459-64. PubMed ID: 641840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cimetidine on digoxin disposition in peptic ulcer patients.
    Garty M; Perry G; Shmueli H; Ilfeld D; Boner G; Pitlik S; Rosenfeld J
    Eur J Clin Pharmacol; 1986; 30(4):489-91. PubMed ID: 3743626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pharmacokinetic parameters of intravenous quinidine and quinine in dogs.
    Clohisy DR; Gibson TP
    J Cardiovasc Pharmacol; 1982; 4(1):107-10. PubMed ID: 6176784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin bioavailability during quinidine administration.
    Hager WD; Mayersohn M; Graves PE
    Clin Pharmacol Ther; 1981 Nov; 30(5):594-9. PubMed ID: 7297019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by basic drugs of digoxin secretion into human bile.
    Hedman A
    Eur J Clin Pharmacol; 1992; 42(4):457-9. PubMed ID: 1516611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone-induced changes in digoxin kinetics.
    Waldorff S; Andersen JD; Heebøll-Nielsen N; Nielsen OG; Moltke E; Sørensen U; Steiness E
    Clin Pharmacol Ther; 1978 Aug; 24(2):162-7. PubMed ID: 679595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers.
    Ding R; Tayrouz Y; Riedel KD; Burhenne J; Weiss J; Mikus G; Haefeli WE
    Clin Pharmacol Ther; 2004 Jul; 76(1):73-84. PubMed ID: 15229466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single- and multiple-dose kinetics of intravenous digoxin.
    Ochs HR; Greenblatt DJ; Bodem G
    Clin Pharmacol Ther; 1980 Sep; 28(3):340-5. PubMed ID: 7408393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.
    Johnson BF; Wilson J; Marwaha R; Hoch K; Johnson J
    Clin Pharmacol Ther; 1987 Jul; 42(1):66-71. PubMed ID: 2954736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.
    Nademanee K; Kannan R; Hendrickson J; Ookhtens M; Kay I; Singh BN
    J Am Coll Cardiol; 1984 Jul; 4(1):111-6. PubMed ID: 6736437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of quinidine on digoxin kinetics in cardiac patients.
    Pedersen KE; Hastrup J; Hvidt S
    Acta Med Scand; 1980; 207(4):291-5. PubMed ID: 7386224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of nonlinearity in digoxin pharmacokinetics.
    Wagner JG; Popat KD; Das SK; Sakmar E; Movahhed H
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):147-66. PubMed ID: 7277206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin-diltiazem interaction: a pharmacokinetic evaluation.
    Jones WN; Kern KB; Rindone JP; Mayersohn M; Bliss M; Goldman S
    Eur J Clin Pharmacol; 1986; 31(3):351-3. PubMed ID: 3792433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of quinidine on the renal clearance of digoxin in the presence of low and high serum digoxin concentrations.
    Clohisy DR; Quintanilla AP; Gibson TP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):49-51. PubMed ID: 7086708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of digoxin-induced inotropism during quinidine administration.
    Steiness E; Waldorff S; Hansen PB; Kjaergård H; Buch J; Egeblad H
    Clin Pharmacol Ther; 1980 Jun; 27(6):791-5. PubMed ID: 7379447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.